Couchbase (BASE) 10-Q7 Jun 232024 Q1 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	3 Months Ended
Cover - shares	Apr. 30, 2023	May 31, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-40601
Entity Registrant Name	Couchbase, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3576987
Entity Address, Street	3250 Olcott Street
Entity Address, City	Santa Clara
Entity Address, State	CA
Entity Address, Postal Zip Code	95054
City Area Code	650
Local Phone Number	417-7500
Title of each class	Common stock, par value $0.00001 per share
Trading Symbol(s)	BASE
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		46,407,718
Entity Central Index Key	0001845022
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 46,240	$ 40,446
Short-term investments	117,403	127,856
Accounts receivable, net	42,212	39,847
Deferred commissions	12,814	13,096
Prepaid expenses and other current assets	6,839	8,234
Total current assets	225,508	229,479
Property and equipment, net	8,032	7,430
Operating lease right-of-use assets	6,233	6,940
Deferred commissions, noncurrent	8,089	7,524
Other assets	1,608	1,666
Total assets	249,470	253,039
Current liabilities
Accounts payable	6,865	1,407
Accrued compensation and benefits	8,495	12,641
Other accrued expenses	4,813	6,076
Operating lease liabilities	3,060	3,117
Deferred revenue	78,540	71,716
Total current liabilities	101,773	94,957
Operating lease liabilities, noncurrent	3,873	4,543
Deferred revenue, noncurrent	2,874	3,275
Total liabilities	108,520	102,775
Commitments and contingencies (Note 9)
Stockholders’ equity
Preferred stock, $0.00001 par value; 200,000,000 shares authorized as of April 30, 2023 and January 31, 2023; zero shares issued outstanding as of April 30, 2023 and January 31, 2023	0	0
Common stock, $0.00001 par value; 1,000,000,000 shares authorized as of April 30, 2023 and January 31, 2023; 46,155,499 and 45,432,029 shares issued and outstanding as of April 30, 2023 and January 31, 2023, respectively	0	0
Additional paid-in capital	573,791	561,547
Accumulated other comprehensive loss	(490)	(807)
Accumulated deficit	(432,351)	(410,476)
Total stockholders’ equity	140,950	150,264
Total liabilities and stockholders’ equity	$ 249,470	$ 253,039

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - $ / shares	Apr. 30, 2023	Jan. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares outstanding (in shares)	46,155,499	45,432,029
Common stock, shares issued (in shares)	46,155,499	45,432,029

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenue:
Total revenue	$ 40,996	$ 34,853
Cost of revenue:
Total cost of revenue	5,922	4,651
Gross profit	35,074	30,202
Operating expenses:
Research and development	15,383	14,421
Sales and marketing	32,553	26,843
General and administrative	9,625	7,926
Restructuring	46	0
Total operating expenses	57,607	49,190
Loss from operations	(22,533)	(18,988)
Interest expense	(25)	(25)
Other income (expense), net	1,433	(556)
Loss before income taxes	(21,125)	(19,569)
Provision for income taxes	750	265
Net loss	$ (21,875)	$ (19,834)
Net loss per share, basic (in dollars per share)	$ (0.48)	$ (0.45)
Net loss per share, diluted (in dollars per share)	$ (0.48)	$ (0.45)
Weighted-average shares used in computing net loss per share, basic (in shares)	45,843	44,265
Weighted-average shares used in computing net loss per share, diluted (in shares)	45,843	44,265
Subscription
Revenue:
Total revenue	$ 38,542	$ 31,981
Cost of revenue:
Total cost of revenue	3,673	2,396
Services
Revenue:
Total revenue	2,454	2,872
Cost of revenue:
Total cost of revenue	2,249	2,255
License \| Subscription
Revenue:
Total revenue	4,943	5,007
Support and other \| Subscription
Revenue:
Total revenue	$ 33,599	$ 26,974

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (21,875)	$ (19,834)
Other comprehensive loss:
Net unrealized gains (losses) on investments, net of tax	317	(686)
Total comprehensive loss	$ (21,558)	$ (20,520)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Jan. 31, 2022	$ 183,215	$ 0	$ 525,392	$ (195)	$ (341,982)
Beginning balance (in shares) at Jan. 31, 2022		43,847,484
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options	2,614		2,614
Issuance of common stock upon exercise of stock options (in shares)		452,313
Issuance of common stock in connection with employee stock purchase plan	3,525		3,525
Issuance of common stock in connection with employee stock purchase plan (in shares)		237,499
Stock-based compensation	5,450		5,450
Net unrealized gains (losses) on investments	(686)			(686)
Net loss	(19,834)				(19,834)
Ending balance at Apr. 30, 2022	174,284	$ 0	536,981	(881)	(361,816)
Ending balance (in shares) at Apr. 30, 2022		44,537,296
Beginning balance at Jan. 31, 2023	$ 150,264	$ 0	561,547	(807)	(410,476)
Beginning balance (in shares) at Jan. 31, 2023	45,432,029	45,432,029
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options	$ 1,917		1,917
Issuance of common stock upon exercise of stock options (in shares)		389,377
Issuance of common stock in connection with employee stock purchase plan	847		847
Issuance of common stock in connection with employee stock purchase plan (in shares)		74,113
Vesting of restricted stock units (in shares)		259,980
Stock-based compensation	9,480		9,480
Net unrealized gains (losses) on investments	317			317
Net loss	(21,875)				(21,875)
Ending balance at Apr. 30, 2023	$ 140,950	$ 0	$ 573,791	$ (490)	$ (432,351)
Ending balance (in shares) at Apr. 30, 2023	46,155,499	46,155,499

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities
Net loss	$ (21,875)	$ (19,834)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	890	739
Stock-based compensation, net of amounts capitalized	9,276	5,450
Amortization of deferred commissions	4,540	4,009
Non-cash lease expense	772	648
Foreign currency transaction (gains) losses	(84)	974
Other	(746)	198
Changes in operating assets and liabilities
Accounts receivable	(2,274)	11,781
Deferred commissions	(4,824)	(3,798)
Prepaid expenses and other assets	1,405	312
Accounts payable	5,458	731
Accrued compensation and benefits	(4,060)	(8,112)
Accrued expenses and other liabilities	(1,256)	(71)
Operating lease liabilities	(826)	(666)
Deferred revenue	6,423	(968)
Net cash used in operating activities	(7,181)	(8,607)
Cash flows from investing activities
Purchases of short-term investments	(7,821)	(53,630)
Maturities of short-term investments	19,423	9,600
Additions to property and equipment	(1,288)	(799)
Net cash provided by (used in) investing activities	10,314	(44,829)
Cash flows from financing activities
Proceeds from exercise of stock options	1,917	2,614
Proceeds from issuance of common stock under ESPP	847	3,525
Net cash provided by financing activities	2,764	6,139
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(103)	(719)
Net increase (decrease) in cash, cash equivalents and restricted cash	5,794	(48,016)
Cash, cash equivalents and restricted cash
Beginning of period	40,989	96,231
End of period	46,783	48,215
Cash and cash equivalents	46,240	47,672
Restricted cash included in other assets	543	543
Total cash, cash equivalents and restricted cash	46,783	48,215
Supplemental disclosures of cash activities
Cash paid for income taxes	294	275
Cash paid for interest	25	25
Non-cash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	204	0
Net change in unrealized gains or losses on available-for-sale debt securities	317	(686)
Change in purchases of property and equipment included in accounts payable and other accrued expenses	$ 0	$ (9)

Description of Business

Description of Business	3 Months Ended
Description of Business	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of BusinessCouchbase, Inc. provides an enterprise-class, multi-cloud NoSQL database architected on top of an open source foundation. Couchbase was incorporated in the State of Delaware in 2008 and is headquartered in Santa Clara, California. In these notes to the unaudited condensed consolidated financial statements, the “Company,” “Couchbase,” “we,” “us” and “our” refers to Couchbase, Inc. and its subsidiaries on a consolidated basis.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2023, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three months ended April 30, 2023, are not necessarily indicative of the results to be expected for the year ending January 31, 2024, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company ’ s Annual Report on Form 10-K for the year ended January 31, 2023, as filed with the SEC on March 29, 2023. Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include, but are not limited to, standalone selling prices for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating lease liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of macroeconomic conditions such as inflation and foreign exchange fluctuations, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. Significant Accounting Policies Other than those described below related to the Company's adoption of ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), there have been no material changes to the Company's significant accounting policies described in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2023, that have had a material impact on its condensed consolidated financial statements and related notes. Short-Term Investments The Company determines the appropriate classification of its investments at the time of purchase. As the Company views these securities as available to support current operations, it accounts for these debt securities as available-for-sale and classifies them as current assets on its condensed consolidated balance sheets. These securities are recorded at estimated fair value. When the fair value of a security declines below its amortized cost basis, the carrying value of the security will be reduced to its fair value if it is more likely than not that management is required to sell the impaired security before recovery of its amortized basis, or management has the intention to sell the security. If neither of these conditions are met, the Company determines whether any portion of the decline is due to credit losses. Any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Company’s condensed consolidated statement of operations. When the fair value of the security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in accumulated other comprehensive income (loss) and are recognized in the Company’s condensed consolidated statement of operations only if the Company sells or intends to sell the security before recovery of its cost basis. Realized gains and losses are determined based on the specific identification method and are reported in interest and other income (expense), net in the Company’s condensed consolidated statements of operations. Accounts Receivable Accounts receivable includes billed and unbilled receivables, net of allowance for credit losses. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is estimated based on the Company’s assessment of the collectibility of accounts receivable by considering various factors, including the age of each outstanding invoice, the collection history of each customer, historical write-off experience, current economic conditions, and reasonable and supportable forecasts of future economic conditions over the life of the receivable. The Company assesses collectibility by reviewing accounts receivable on an aggregate basis when similar characteristics exist and on an individual basis when specific customers with collectibility issues are identified. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk primarily consist of cash, cash equivalents, restricted cash, short-term investments and accounts receivable. The Company maintains its cash and cash equivalents, restricted cash and short-term investments with high-quality financial institutions. Cash equivalents consist of money market funds which are invested through financial institutions in the United States. Deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on these deposits. For its accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheet. Generally, credit risk with respect to accounts receivable is diversified due to the number of entities comprising the Company’s customer base and their dispersion across different geographies and industries. The Company performs ongoing credit evaluations on certain customers and generally does not require collateral on accounts receivable. The Company maintains an allowance for doubtful accounts and historically bad debts have not been material. No customer accounte d for 10% or more of total revenue for the three months ended April 30, 2023 and 2022. One customer accounted for approximately 11% of gross accounts receivable as of April 30, 2023 and one customer accounted for approximately 12% of gross accounts receivable as of January 31, 2023. Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company adopted this standard effective February 1, 2023 on a modified retrospective basis, and the adoption did not result in any cumulative effect adjustment in the condensed consolidated financial statements. Recently Issued Accounting Pronouncements Under the Jumpstart Our Business Startups Act (the “JOBS Act ” ), the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period.

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	3 Months Ended
Cash Equivalents and Short-Term Investments	Apr. 30, 2023
Cash, Cash Equivalents, and Short-Term Investments [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments The following tables summarize the Company’s cash equivalents and short-term investments (in thousands): As of April 30, 2023 Amortized Gross Gross Estimated Cash Equivalents Money market funds $ 13,484 $ — $ — $ 13,484 Total cash equivalents 13,484 — — 13,484 Short-Term Investments U.S. government treasury securities 63,309 — (452) 62,857 Commercial paper 25,597 — — 25,597 U.S. government agency securities 11,881 16 (2) 11,895 Corporate debt securities 11,919 — (25) 11,894 Asset-backed securities 5,187 — (27) 5,160 Total short-term investments 117,893 16 (506) 117,403 Total $ 131,377 $ 16 $ (506) $ 130,887 As of January 31, 2023 Amortized Gross Gross Estimated Cash Equivalents Money market funds $ 29,239 $ — $ — $ 29,239 Corporate debt securities $ 1,122 $ — $ — 1,122 Total cash equivalents 30,361 — — 30,361 Short-Term Investments U.S. government treasury securities 71,981 1 (729) 71,253 Commercial paper 31,500 — — 31,500 U.S. government agency securities 7,839 3 (1) 7,841 Corporate debt securities 11,952 — (50) 11,902 Asset-backed securities 5,391 — (31) 5,360 Total short-term investments 128,663 4 (811) 127,856 Total $ 159,024 $ 4 $ (811) $ 158,217 During the three months ended April 30, 2023 and 2022, the Company did not reclassify any amounts to earnings from accumulated other comprehensive income (loss) related to unrealized gains or losses in other income (expense), net in the condensed consolidated statements of operations. As of April 30, 2023, the Company’s short-term investments consisted of $111.4 million and $6.0 million with a contractual maturity date of less than one year and greater than one year, respectively. As of January 31, 2023, the Company’s short-term investments consisted of $122.0 million and $5.9 million with a contractual maturity of less than one year and greater than one year, respectively. The Company’s gross unrealized losses and fair values for short-term investments that were in an unrealized loss position as of April 30, 2023 and January 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position were as follows (in thousands): As of April 30, 2023 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government treasury securities $ (135) $ 38,243 $ (317) $ 24,615 $ (452) $ 62,858 Corporate debt securities (25) 10,894 — — (25) 10,894 Asset-backed securities (27) 5,160 — — (27) 5,160 U.S. government agency securities (2) 3,941 — — (2) 3,941 Total $ (189) $ 58,238 $ (317) $ 24,615 $ (506) $ 82,853 As of January 31, 2023 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government treasury securities $ (729) $ 64,397 $ — $ — $ (729) $ 64,397 Corporate debt securities (49) 8,909 (1) 1,999 (50) 10,908 Asset-backed securities (31) 5,359 — — (31) 5,359 U.S. government agency securities (1) 1,918 — — (1) 1,918 Total $ (810) $ 80,583 $ (1) $ 1,999 $ (811) $ 82,582 As of April 30, 2023, the Company had 28 short-term investments in an unrealized loss position. As of January 31, 2023, the Company had 27 short-term investments in an unrealized loss position. As of April 30, 2023, the Company determined that the declines in the market value of its investment portfolio were not driven by credit related factors. During the three months ended April 30, 2023, the Company did not recognize any losses on its short-term investments due to credit related factors.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
Fair Value Measurements	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company accounts for certain of its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts reflected on the condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short maturities of those instruments. The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands): As of April 30, 2023 Level 1 Level 2 Total Cash Equivalents Money market funds $ 13,484 $ — $ 13,484 Total cash equivalents 13,484 — 13,484 Short-Term Investments U.S. government treasury securities — 62,857 62,857 Commercial paper — 25,597 25,597 U.S. government agency securities — 11,895 11,895 Corporate debt securities — 11,894 11,894 Asset-backed securities — 5,160 5,160 Total short-term investments — 117,403 117,403 Total $ 13,484 $ 117,403 $ 130,887 As of January 31, 2023 Level 1 Level 2 Total Cash Equivalents Money market funds $ 29,239 $ — $ 29,239 Corporate debt securities $ — 1,122 1,122 Total cash equivalents 29,239 1,122 30,361 Short-Term Investments U.S. government treasury securities — 71,253 71,253 Commercial paper — 31,500 31,500 U.S. government agency securities — 7,841 7,841 Corporate debt securities — 11,902 11,902 Asset-backed securities — 5,360 5,360 Total short-term investments — 127,856 127,856 Total $ 29,239 $ 128,978 $ 158,217 The Company classifies its money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its U.S. government agency securities, asset-backed securities, commercial paper, U.S. government treasury securities, and corporate debt securities within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Balance Sheet Components

Balance Sheet Components	3 Months Ended
Balance Sheet Components	Apr. 30, 2023
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Prepaid expenses $ 2,860 $ 4,140 Prepaid software 3,143 2,560 Other current assets 836 1,534 Total prepaid expenses and other current assets $ 6,839 $ 8,234 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Computer equipment $ 3,562 $ 3,586 Furniture and fixtures 342 342 Capitalized internal-use software 8,435 7,884 Leasehold improvements 1,889 1,889 Construction in progress—capitalized internal-use software 4,336 3,395 Total gross property and equipment 18,564 17,096 Accumulated depreciation and amortization (10,532) (9,666) Total property and equipment, net $ 8,032 $ 7,430 Depreciation and amortization expense was $0.9 million and $0.7 million for three months ended April 30, 2023 and 2022, respectively. Included in these amounts were the amortization of capitalized internal-use software development costs of $0.7 million and $0.5 million in the three months ended April 30, 2023 and 2022, respectively. Accrued Compensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Accrued bonus $ 2,528 $ 5,944 Accrued commissions 3,442 3,593 Accrued payroll and benefits 2,041 1,995 Employee contributions under the ESPP 484 1,109 Total accrued compensation and benefits $ 8,495 $ 12,641 Other Accrued Expenses Other accrued expenses consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Accrued professional fees $ 913 $ 1,020 Sales and value added tax payable 830 737 Income taxes payable 1,064 743 Accrued restructuring 74 1,567 Other 1,932 2,009 Total other accrued expenses $ 4,813 $ 6,076

Deferred Revenue and Remaining

Deferred Revenue and Remaining Performance Obligations	3 Months Ended
Deferred Revenue and Remaining Performance Obligations	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Remaining Performance Obligations	Deferred Revenue and Remaining Performance Obligations The following table presents the deferred revenue balances (in thousands): As of April 30, As of January 31, 2023 2023 Deferred revenue, current $ 78,540 $ 71,716 Deferred revenue, noncurrent 2,874 3,275 Total deferred revenue $ 81,414 $ 74,991 Changes in the deferred revenue balances during the three months ended April 30, 2023 and 2022 were as follows (in thousands): Three Months Ended April 30, 2023 2022 Beginning balance $ 74,991 $ 71,723 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (29,061) (24,207) Increases due to invoicing prior to satisfaction of performance obligations 35,484 23,239 Ending balance $ 81,414 $ 70,755 Remaining performance obligations (“RPOs”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of April 30, 2023, the Company’s RPOs were $165.6 million. The Company expects to recognize revenue of $112.1 million of these remaining performance obligations over the next twelve months with the remaining balances recognized thereafter.

Debt

Debt	3 Months Ended
Debt	Apr. 30, 2023
Debt Disclosure [Abstract]
Debt	ebt Interest expense consisting primarily of unused Credit Facility (as defined below) fees was immaterial for the three months ended April 30, 2023 and 2022. Term Loan In August 2018, the Company entered into an agreement for a term loan with a certain lender, which was amended in April 2019 and in June 2020 (the “Amended Loan”). The Amended Loan provided maximum borrowings of up to $25.0 million, maturing in June 2024. In January 2021, the Company repaid all outstanding indebtedness owed pursuant to the Amended Loan and terminated the agreement. Pursuant to the termination of the Amended Loan, the related security interests have been removed and the covenants shall be of no further force and effect. In connection with the April 2019 amendment, the Company issued warrants to purchase 105,350 shares of the Company’s common stock at $7.48 per share, exercisable over 10 years. The fair value of the warrants was recorded to equity and as a debt discount that was amortized to interest over the term of the loan. The total fair value of the common stock warrants was $0.4 million. As of April 30, 2023, all warrants were outstanding and exercisable. Credit Facility In January 2021, the Company entered into an Amended and Restated Loan and Security Agreement with Silicon Valley Bank (the “Credit Facility”) providing the Company the ability to borrow up to $40.0 million from a revolving line of credit and extending the maturity date to January 2024. Upon the execution of the amended Credit Facility, the Company borrowed $25.0 million from the line of credit, which was repaid in full during the fiscal year ended January 31, 2022. The line of credit was secured with a pledge on substantially all the assets of the Company, except any intellectual property and was subject to a minimum revenue covenant. The amendment also added certain financial covenants, including covenants related to certain financial metrics, that if not met, would limit the amount of additional borrowings under the line of credit. The amended line of credit agreement also required the company to maintain an adjusted quick ratio (as defined by the agreement) of at least 1.15 to 1.0. The line of credit agreement also contained certain customary affirmative and negative covenants as well as customary events of default, subject to certain exceptions, including restrictions on the Company’s ability to, among other things, incur debt and liens, maintain collateral accounts, undergo fundamental changes including mergers or consolidations, dispose assets including selling, transferring or assigning assets, pay dividends or other distributions or make or permit payments on any subordinated debt. The outstanding principal balance was due at maturity with interest payable monthly. The line of credit bore a variable annual interest rate of the prime rate plus 0.5%. The Company was required to pay a fee equal to 0.25% per annum on the unused portion of the line of credit. The Company was also subject to a termination fee ranging from 0.5% to 1.0% of the line of credit if the Company terminates the agreement prior to the maturity date. The Company was in compliance with the financial covenants under the line of credit as of April 30, 2023. There were no borrowings outstanding against the line of credit as of April 30, 2023. As of April 30, 2023, $40.0 million was available for borrowing under the line of credit. On March 14, 2023, Silicon Valley Bridge Bank, N.A. announced that it had assumed the obligations and commitments of former Silicon Valley Bank, including the line of credit. In March 2023, Silicon Valley Bridge Bank, N.A. became a division of First-Citizens Bank & Trust Company. The agreements that governed the former Silicon Valley Bank relationship remained in place. There were no changes to the terms of the Credit Facility and the Company had full access to its cash balances. On June 5, 2023, the Company terminated the Credit Facility pursuant to Section 12.1 thereof. Any termination fee owed by the Company as required by Section 2.5(c) thereof has been waived by Silicon Valley Bank. At the time of termination, no borrowings were outstanding under the Credit Facility. Concurrently with the termination of the Credit Facility, all liens securing the Company’s obligations under the Credit Facility were released.

Leases

Leases	3 Months Ended
Leases	Apr. 30, 2023
Leases [Abstract]
Leases	Leases The Company leases facilities under non-cancelable operating leases, primarily for rent of office space. Our leases have various expiration dates through November 2027, some of which include options to extend the leases for up to three years. The Company does not have any finance leases. Operating lease costs were $0.8 million and $0.6 million for the three months ended April 30, 2023 and 2022, respectively. Variable lease costs were $0.1 million and $0.2 million during the three months ended April 30, 2023 and 2022, respectively. Short-term lease costs were immaterial during the three months ended April 30, 2023 and 2022. The following table presents supplemental cash flow information related to leases: Three Months Ended April 30, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows from operating leases $ 823 $ 661 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ — $ 1,509 The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate): April 30, 2023 January 31, 2023 Operating lease right-of-use assets $ 6,233 $ 6,940 Operating lease liabilities $ 3,060 $ 3,117 Operating lease liabilities, noncurrent 3,873 4,543 Total operating lease liabilities $ 6,933 $ 7,660 Weighted-average remaining lease term 2.5 years 2.7 years Weighted-average discount rate 3.8 % 3.8 % As of April 30, 2023, remaining maturities of operating lease liabilities were as follows (in thousands): Period Operating Leases Remaining for Fiscal 2024 $ 2,492 Fiscal 2025 2,988 Fiscal 2026 1,183 Fiscal 2027 353 Fiscal 2028 and thereafter 251 Total lease payments 7,267 Less: imputed interest (334) Total $ 6,933

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Other Contractual Commitments Other contractual commitments relate to third-party cloud infrastructure agreements and subscription arrangements. As of April 30, 2023, there were no material changes to the Co mpany’s contractual commitments since January 31, 2023. Legal Matters From time to time, the Company may be a party to various legal matters, threatened claims, or proceedings in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and contingencies. Legal accruals are recorded when and if it is determined that a loss related to a certain matter is both probable and reasonably estimable. The Company is not currently a party to any legal proceedings that, if determined adversely to it, would, in management’s opinion, have a material and adverse effect on the Company’s financial condition, results of operations, or cash flows. Indemnification Agreements In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which the Company agrees to indemnify customers, vendors, lessors and other business partners with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. Additionally, the Company entered into indemnification agreements with the Company’s directors and officers that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements nor are we aware of any such claims that could reasonably be expected to incur material costs.

Stockholders_ Equity and Employ

Stockholders’ Equity and Employee Incentive Plans	3 Months Ended
Stockholders’ Equity and Employee Incentive Plans	Apr. 30, 2023
Equity And Compensation Related Costs Share Based Payments [Abstract]
Stockholders’ Equity and Employee Incentive Plans	Stockholders’ Equity and Employee Incentive Plans Redeemable Convertible Preferred Stock As of April 30, 2023, there were no shares of redeemable convertible preferred stock issued and outstanding. The Company’s Amended and Restated Certificate of Incorporation authorizes the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. Common Stock The Company’s Amended and Restated Certificate of Incorporation authorized the Company to issue 1,000,000,000 shares of common stock at a par value of $0.00001 as of April 30, 2023 and January 31, 2023. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. As of April 30, 2023 and January 31, 2023, no dividends had been declared. As of April 30, 2023, the Company has reserved common stock for future issuance as follows: Number of Shares Stock options outstanding 7,387,648 Restricted stock units issued and outstanding 6,573,473 Remaining shares available for issuance under the 2021 Plan 2,207,333 Shares available for issuance under the 2023 Inducement Plan 1,139,968 ESPP 1,334,366 Common stock warrants 105,350 Total 18,748,138 Stock Plans The Company has four equity incentive plans: the 2008 Equity Incentive Plan (the “2008 Plan”), 2018 Equity Incentive Plan (the “2018 Plan”), 2021 Equity Incentive Plan (the “2021 Plan”) and 2023 Inducement Equity Incentive Plan (the "2023 Inducement Plan"), collectively (the “Stock Plans”). In connection with the Company’s IPO in July 2021, the 2008 Plan and the 2018 Plan were terminated and replaced by the 2021 Plan and all shares that remained available for issuance under the 2018 Plan at that time were reserved for issuance under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will be increased by any shares of common stock subject to awards outstanding under the 2008 Plan and the 2018 Plan that expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by the Company for payment of an exercise price or for satisfying tax withholding obligations or are forfeited to or repurchased by the Company due to failure to vest. The Company has issued stock options to employees, directors, consultants and advisors pursuant to the 2018 Plan and restricted stock units (“RSUs”) under the 2021 Plan. Equity awards permitted under the 2021 Plan may be stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Stock option grants may be either Incentive Stock Options (“ISO”) or Non-Qualified Stock Options (“NSO”). ISO may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, consultants, and nonemployee directors. Employee stock options are granted with an exercise price no less than the fair value of the underlying common stock on the grant date. Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter. As of April 30, 2023, there were 2.2 million shares available for grant under the 2021 Plan. The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year. During the fiscal year ended January 31, 2023, the Company adopted the 2023 Inducement Equity Incentive Plan (the “2023 Inducement Plan”), pursuant to which the Company reserved 1,300,000 shares of its common stock to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, as an inducement material to the individual’s entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules. The maximum number of shares of our common stock that may be issued under the 2023 Inducement Plan will not exceed 1,300,000 shares. The 2023 Inducement Plan was approved by the Company’s Board of Directors without stockholder approval in accordance with such rule. As of April 30, 2023, there were 1.1 million shares available for grant under the 2023 Inducement Plan. Employee Stock Purchase Plan In July 2021, the Company established an Employee Stock Purchase Plan (“ESPP”) in which eligible employees may contribute up to 15% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of (1) the fair market value of a share of the Company’s common stock at the beginning of the offering period and (2) the fair market value of a share of the Company’s common stock on the purchase date. A participant will be permitted to purchase a maximum of shares during each offering period and no participant may purchase more than 1,000 shares during any offering period. Except for the initial offering period, the ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering period consists of four purchase periods with the first purchase date on March 21, 2022, and the final purchase period ending on September 20, 2023. The Company recognized stock-based compensation expense related to the ESPP of $0.3 million and $0.8 million during the three months ended April 30, 2023 and 2022, respectively. As of April 30, 2023, accrued ESPP employee payroll contributions of $0.5 million are included within accrued compensation and benefits in the consolidated balance sheet. ESPP payroll contributions used to purchase shares are reclassified to stockholders’ equity on the purchase date. As of April 30, 2023, $0.9 million of unrecognized stock-based compensation expense related to the ESPP is expected to be recognized over a weighted-average vesting period of 0.7 years. During the three months ended April 30, 2023, 74,113 shares of common stock were issued under the ESPP. Stock Options The following table summarizes stock option activity under the Stock Plans for the three months ended April 30, 2023 (aggregate intrinsic value in thousands): Options Outstanding Weighted- Aggregate Number of Weighted- Balances as of January 31, 2023 7,819,480 $ 9.78 5.21 $ 51,606 Options exercised (389,377) $ 4.92 Options granted — $ — Options cancelled (42,455) $ 19.59 Balances as of April 30, 2023 7,387,648 $ 9.98 5.18 $ 50,996 Options vested and expected to vest as of April 30, 2023 7,387,648 $ 9.98 5.18 $ 50,996 Options vested and exercisable as of April 30, 2023 6,318,721 $ 8.62 4.76 $ 48,584 No stock options were granted during the three months ended April 30, 2023 and 2022. The aggregate intrinsic value of options exercised during the three months ended April 30, 2023 and 2022 was $4.2 million and $6.7 million, respectively. Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock. The Company recognized stock-based compensation expense related to stock options of $1.2 million and $1.7 million during the three months ended April 30, 2023 and 2022, respectively. As of April 30, 2023, there was $7.5 million of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.5 years. Service-Based RSUs During the year ended January 31, 2022, the Company began granting RSUs to its employees. RSUs granted had service-based vesting conditions. The service-based vesting condition for these awards is generally satisfied by rendering continuous service over two to four years, depending on the award, during which time the grants will vest quarterly. The following table is a summary of service-based RSU activity for the three months ended April 30, 2023: RSUs Outstanding Number of RSUs Weighted Average Grant Date Fair Value Per Share Balances as of January 31, 2023 3,442,982 $ 18.39 RSUs granted 2,415,445 $ 16.26 RSUs vested (259,980) $ 19.88 RSUs forfeited (154,974) $ 17.62 Balances as of April 30, 2023 5,443,473 $ 17.39 The aggregate fair value of the RSU awards granted was $39.3 million and $49.7 million during the three months ended April 30, 2023 and 2022, respectively. This represents the fair value of the common stock on the date the service-based vesting awards were granted. We recognized $6.8 million and $2.4 million in stock-based compensation expense related to service vesting-based RSUs during the three months ended April 30, 2023 and 2022, respectively. As of April 30, 2023, there was $86.4 million of unrecognized compensation expense related to service-based RSUs expected to be recognized over a weighted-average vesting period of 2.7 years. Modification of Market-Based Awards On March 20, 2023, the Board of Directors approved a modification of the Company’s 1,060,000 outstanding Market-based RSUs granted to certain executive officers and members of senior management. This resulted in 840,000 of the awards modified to performance-based vesting and the other 220,000 remained market-based vesting with modified stock price targets and requisite service periods. Performance-based Awards The 840,000 awards granted to certain executive officers were modified from market-based vesting conditions to performance-based vesting conditions and will vest based on the Company achieving certain financial metrics over revised service periods. For the portion of the awards where the expectation of the achievement of performance conditions remained probable prior to and post modification, the Company accounted for this change as a Type I modification under ASC 718, Compensation—Stock Compensation. For the portion of the awards where the expectation of the achievement of performance conditions changed from probable prior to the modification to improbable post-modification, the Company accounted for this change as a Type II modification. The Company recognizes expense for performance-based RSUs over the requisite service period based on management's expectation of the number of performance-based RSUs expected to vest. For any change in the expectation of the number of performance-based RSUs that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The incremental stock-based compensation expense related to these modified awards was $6.0 million, of which the Company recognized $0.4 million during the three months ended April 30, 2023. During the three months ended April 30, 2023, the Company granted 70,000 performance-based RSUs to an executive officer pursuant to the 2021 Plan with vesting conditions identical to the modified awards discussed above. The grant date fair value of the award was $0.7 million. We recognized a total of $0.7 million in stock-based compensation expense related to performance-based vesting RSUs during the three months ended April 30, 2023. As of April 30, 2023, there was $9.9 million of unrecognized compensation expense related to performance-based RSUs expected to be recognized over an average vesting period of 1.6 years. Market-based Awards The 220,000 awards granted to certain members of senior management were modified to revise the 60-trading day stock price target of the Company’s common stock and the requisite service periods. The incremental stock-based compensation expense related to these modified awards was not material. As of April 30, 2023, there was a total of $2.2 million of unrecognized compensation expense related to market-based RSUs expected to be recognized over an average vesting period of 1.5 years. Determination of Fair Value The Company estimates the fair value of stock options and purchase rights issued to employees under the ESPP using the Black-Scholes option-pricing model, which is dependent upon several variables, such as the fair value of the Company’s common stock, the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, and expected dividend yield. Expected term —The expected term represents the weighted-average period the stock options are expected to remain outstanding and is calculated using the simplified method, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the expected term as the midpoint between the vesting date and the contractual expiration date of the option. Expected volatility —The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have sufficient trading history for the Company’s common stock. Risk-free interest rate —The risk-free rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s awards. Dividend yield —The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Fair value of underlying common stock — Prior to the Company’s IPO, the fair value was determined by the Board of Directors with input from management and contemporaneous independent third-party valuations. Subsequent to the IPO, the fair value of the Company’s common stock is based on the daily average selling price on the Nasdaq Global Select Market. No stock options were granted during the three months ended April 30, 2023 or 2022. The fair value of employee stock purchase rights for the offering period under the 2021 ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: Three Months Ended April 30, 2023 2022 Employee Stock Purchase Plan: Expected term (in years) 0.8 1.6 Expected volatility 66.9 % 49.4 % Risk-free interest rate 4.8 % 0.2 % Dividend yield — — Stock-Based Compensation Stock-based compensation expense, net of amounts capitalized was as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of revenue—subscription $ 193 $ 122 Cost of revenue—services 145 94 Research and development 2,768 1,899 Sales and marketing 3,241 1,987 General and administrative 2,928 1,348 Restructuring 1 — Total stock-based compensation expense $ 9,276 $ 5,450

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and records a cumulative adjustment in such period. The Company recorded income tax expense of $0.8 million and $0.3 million for the three months ended April 30, 2023 and 2022, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on the Company’s domestic deferred tax assets, including net operating loss carryforwards, research and development tax credits, capitalized research and development, and other book versus tax differences was maintained. The Company has deferred tax attributes for stock-based compensation and fixed assets in the United Kingdom, and has deemed no valuation allowance is necessary at this point. The Company will continue to evaluate for any future developments.

Restructuring

Restructuring	3 Months Ended
Restructuring	Apr. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring	RestructuringDuring the fiscal year ended January 31, 2023, the Company initiated a restructuring plan to improve operational efficiency. This resulted in severance and related costs and stock-based compensation related to modifications of vested awards granted to certain employees impacted by the restructuring plan. As of April 30, 2023, the restructuring plan is substantially complete. Restructuring expense was as follows (in thousands): Three Months Ended April 30, 2023 Employee severance and related costs $ 45 Stock-based compensation 1 Total restructuring charges $ 46 Accrued Restructuring Restructuring liabilities are reported within accrued expenses in the condensed consolidated balance sheets. An immaterial amount was paid during the year ended January 31, 2023. The activity in our restructuring liabilities for the three months ended April 30, 2023 is as follows (in thousands): Total Balance as of January 31, 2023 $ 1,567 Restructuring charges and adjustments 45 Payments (1,538) Balance as of April 30, 2023 $ 74

Geographic Information

Geographic Information	3 Months Ended
Geographic Information	Apr. 30, 2023
Segment Reporting [Abstract]
Geographic Information	Geographic Information The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands): Three Months Ended April 30, 2023 2022 United States $ 25,991 $ 21,336 International 15,005 13,517 Total $ 40,996 $ 34,853 No individual foreign country contributed 10% or more of total revenue for the three months ended April 30, 2023 and 2022. As of April 30, 2023 and January 31, 2023, the majority of the Company’s long-lived assets, including operating lease ROU assets, were located in the United States.

Net Loss per Share

Net Loss per Share	3 Months Ended
Net Loss per Share	Apr. 30, 2023
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per ShareBasic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all years presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented. The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended April 30, 2023 2022 Numerator Net loss $ (21,875) $ (19,834) Denominator Weighted-average shares used in computing net loss per share, basic and diluted 45,843 44,265 Net loss per share, basic and diluted $ (0.48) $ (0.45) The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands): Three Months Ended April 30, 2023 2022 Stock options 7,388 8,604 RSUs 6,983 3,957 Employee stock purchase rights under the ESPP 118 138 Common stock warrants 105 105 Total 14,594 12,804

Subsequent Event

Subsequent Event	3 Months Ended
Subsequent Event	Apr. 30, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventOn June 5, 2023, the Company terminated the Credit Facility pursuant to Section 12.1 thereof. Any termination fee owed by the Company as required by Section 2.5(c) thereof has been waived by Silicon Valley Bank. At the time of termination, no borrowings were outstanding under the Credit Facility. Concurrently with the termination of the Credit Facility, all liens securing the Company’s obligations under the Credit Facility were released.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2023, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three months ended April 30, 2023, are not necessarily indicative of the results to be expected for the year ending January 31, 2024, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in the Company ’ s Annual Report on Form 10-K for the year ended January 31, 2023, as filed with the SEC on March 29, 2023.
Fiscal Year	Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include, but are not limited to, standalone selling prices for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, valuation of stock-based awards, the determination of allowance for doubtful accounts, the incremental borrowing rate used to measure operating lease liabilities, and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of macroeconomic conditions such as inflation and foreign exchange fluctuations, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected.
Short-Term Investments	Short-Term Investments The Company determines the appropriate classification of its investments at the time of purchase. As the Company views these securities as available to support current operations, it accounts for these debt securities as available-for-sale and classifies them as current assets on its condensed consolidated balance sheets. These securities are recorded at estimated fair value. When the fair value of a security declines below its amortized cost basis, the carrying value of the security will be reduced to its fair value if it is more likely than not that management is required to sell the impaired security before recovery of its amortized basis, or management has the intention to sell the security. If neither of these conditions are met, the Company determines whether any portion of the decline is due to credit losses. Any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Company’s condensed consolidated statement of operations. When the fair value of the security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in accumulated other comprehensive income (loss) and are recognized in the Company’s condensed consolidated statement of operations only if the Company sells or intends to sell the security before recovery of its cost basis. Realized gains and losses are determined based on the specific identification method and are reported in interest and other income (expense), net in the Company’s condensed consolidated statements of operations.
Accounts Receivable	Accounts ReceivableAccounts receivable includes billed and unbilled receivables, net of allowance for credit losses. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is estimated based on the Company’s assessment of the collectibility of accounts receivable by considering various factors, including the age of each outstanding invoice, the collection history of each customer, historical write-off experience, current economic conditions, and reasonable and supportable forecasts of future economic conditions over the life of the receivable. The Company assesses collectibility by reviewing accounts receivable on an aggregate basis when similar characteristics exist and on an individual basis when specific customers with collectibility issues are identified. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk primarily consist of cash, cash equivalents, restricted cash, short-term investments and accounts receivable. The Company maintains its cash and cash equivalents, restricted cash and short-term investments with high-quality financial institutions. Cash equivalents consist of money market funds which are invested through financial institutions in the United States. Deposits, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on these deposits. For its accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheet. Generally, credit risk with respect to accounts receivable is diversified due to the number of entities comprising the Company’s customer base and their dispersion across different geographies and industries. The Company performs ongoing credit evaluations on certain customers and generally does not require collateral on accounts receivable. The Company maintains an allowance for doubtful accounts and historically bad debts have not been material.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company adopted this standard effective February 1, 2023 on a modified retrospective basis, and the adoption did not result in any cumulative effect adjustment in the condensed consolidated financial statements. Recently Issued Accounting Pronouncements Under the Jumpstart Our Business Startups Act (the “JOBS Act ” ), the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period.

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	3 Months Ended
Cash Equivalents and Short-Term Investments (Tables)	Apr. 30, 2023
Cash, Cash Equivalents, and Short-Term Investments [Abstract]
Schedule of Cash Equivalents and Short-term Investments	The following tables summarize the Company’s cash equivalents and short-term investments (in thousands): As of April 30, 2023 Amortized Gross Gross Estimated Cash Equivalents Money market funds $ 13,484 $ — $ — $ 13,484 Total cash equivalents 13,484 — — 13,484 Short-Term Investments U.S. government treasury securities 63,309 — (452) 62,857 Commercial paper 25,597 — — 25,597 U.S. government agency securities 11,881 16 (2) 11,895 Corporate debt securities 11,919 — (25) 11,894 Asset-backed securities 5,187 — (27) 5,160 Total short-term investments 117,893 16 (506) 117,403 Total $ 131,377 $ 16 $ (506) $ 130,887 As of January 31, 2023 Amortized Gross Gross Estimated Cash Equivalents Money market funds $ 29,239 $ — $ — $ 29,239 Corporate debt securities $ 1,122 $ — $ — 1,122 Total cash equivalents 30,361 — — 30,361 Short-Term Investments U.S. government treasury securities 71,981 1 (729) 71,253 Commercial paper 31,500 — — 31,500 U.S. government agency securities 7,839 3 (1) 7,841 Corporate debt securities 11,952 — (50) 11,902 Asset-backed securities 5,391 — (31) 5,360 Total short-term investments 128,663 4 (811) 127,856 Total $ 159,024 $ 4 $ (811) $ 158,217
Summary of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value	The Company’s gross unrealized losses and fair values for short-term investments that were in an unrealized loss position as of April 30, 2023 and January 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position were as follows (in thousands): As of April 30, 2023 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government treasury securities $ (135) $ 38,243 $ (317) $ 24,615 $ (452) $ 62,858 Corporate debt securities (25) 10,894 — — (25) 10,894 Asset-backed securities (27) 5,160 — — (27) 5,160 U.S. government agency securities (2) 3,941 — — (2) 3,941 Total $ (189) $ 58,238 $ (317) $ 24,615 $ (506) $ 82,853 As of January 31, 2023 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government treasury securities $ (729) $ 64,397 $ — $ — $ (729) $ 64,397 Corporate debt securities (49) 8,909 (1) 1,999 (50) 10,908 Asset-backed securities (31) 5,359 — — (31) 5,359 U.S. government agency securities (1) 1,918 — — (1) 1,918 Total $ (810) $ 80,583 $ (1) $ 1,999 $ (811) $ 82,582

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
Fair Value Measurements (Tables)	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands): As of April 30, 2023 Level 1 Level 2 Total Cash Equivalents Money market funds $ 13,484 $ — $ 13,484 Total cash equivalents 13,484 — 13,484 Short-Term Investments U.S. government treasury securities — 62,857 62,857 Commercial paper — 25,597 25,597 U.S. government agency securities — 11,895 11,895 Corporate debt securities — 11,894 11,894 Asset-backed securities — 5,160 5,160 Total short-term investments — 117,403 117,403 Total $ 13,484 $ 117,403 $ 130,887 As of January 31, 2023 Level 1 Level 2 Total Cash Equivalents Money market funds $ 29,239 $ — $ 29,239 Corporate debt securities $ — 1,122 1,122 Total cash equivalents 29,239 1,122 30,361 Short-Term Investments U.S. government treasury securities — 71,253 71,253 Commercial paper — 31,500 31,500 U.S. government agency securities — 7,841 7,841 Corporate debt securities — 11,902 11,902 Asset-backed securities — 5,360 5,360 Total short-term investments — 127,856 127,856 Total $ 29,239 $ 128,978 $ 158,217

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
Balance Sheet Components (Tables)	Apr. 30, 2023
Balance Sheet Related Disclosures [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Prepaid expenses $ 2,860 $ 4,140 Prepaid software 3,143 2,560 Other current assets 836 1,534 Total prepaid expenses and other current assets $ 6,839 $ 8,234
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Computer equipment $ 3,562 $ 3,586 Furniture and fixtures 342 342 Capitalized internal-use software 8,435 7,884 Leasehold improvements 1,889 1,889 Construction in progress—capitalized internal-use software 4,336 3,395 Total gross property and equipment 18,564 17,096 Accumulated depreciation and amortization (10,532) (9,666) Total property and equipment, net $ 8,032 $ 7,430
Schedule of Accrued Compensation and Benefits	Accrued compensation and benefits consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Accrued bonus $ 2,528 $ 5,944 Accrued commissions 3,442 3,593 Accrued payroll and benefits 2,041 1,995 Employee contributions under the ESPP 484 1,109 Total accrued compensation and benefits $ 8,495 $ 12,641
Schedule of Other Accrued Expenses	Other accrued expenses consisted of the following (in thousands): As of April 30, As of January 31, 2023 2023 Accrued professional fees $ 913 $ 1,020 Sales and value added tax payable 830 737 Income taxes payable 1,064 743 Accrued restructuring 74 1,567 Other 1,932 2,009 Total other accrued expenses $ 4,813 $ 6,076

Deferred Revenue and Remainin_2

Deferred Revenue and Remaining Performance Obligations (Tables)	3 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Deferred Revenue Balances and Changes in Deferred Revenues Balances	The following table presents the deferred revenue balances (in thousands): As of April 30, As of January 31, 2023 2023 Deferred revenue, current $ 78,540 $ 71,716 Deferred revenue, noncurrent 2,874 3,275 Total deferred revenue $ 81,414 $ 74,991 Changes in the deferred revenue balances during the three months ended April 30, 2023 and 2022 were as follows (in thousands): Three Months Ended April 30, 2023 2022 Beginning balance $ 74,991 $ 71,723 Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year (29,061) (24,207) Increases due to invoicing prior to satisfaction of performance obligations 35,484 23,239 Ending balance $ 81,414 $ 70,755

Leases (Tables)

Leases (Tables)	3 Months Ended
Leases (Tables)	Apr. 30, 2023
Leases [Abstract]
Schedule of Supplemental Cash Flow Related to Leases	The following table presents supplemental cash flow information related to leases: Three Months Ended April 30, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows from operating leases $ 823 $ 661 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ — $ 1,509
Schedule of Supplemental Balance Sheet Information	The following table presents supplemental balance sheet information related to operating leases (in thousands, except for lease term and discount rate): April 30, 2023 January 31, 2023 Operating lease right-of-use assets $ 6,233 $ 6,940 Operating lease liabilities $ 3,060 $ 3,117 Operating lease liabilities, noncurrent 3,873 4,543 Total operating lease liabilities $ 6,933 $ 7,660 Weighted-average remaining lease term 2.5 years 2.7 years Weighted-average discount rate 3.8 % 3.8 %
Schedule of Operating Lease Maturities	As of April 30, 2023, remaining maturities of operating lease liabilities were as follows (in thousands): Period Operating Leases Remaining for Fiscal 2024 $ 2,492 Fiscal 2025 2,988 Fiscal 2026 1,183 Fiscal 2027 353 Fiscal 2028 and thereafter 251 Total lease payments 7,267 Less: imputed interest (334) Total $ 6,933

Stockholders_ Equity and Empl_2

Stockholders’ Equity and Employee Incentive Plans (Tables)	3 Months Ended
Stockholders’ Equity and Employee Incentive Plans (Tables)	Apr. 30, 2023
Equity And Compensation Related Costs Share Based Payments [Abstract]
Schedule of Reserved Common Stock for Future Issuance	As of April 30, 2023, the Company has reserved common stock for future issuance as follows: Number of Shares Stock options outstanding 7,387,648 Restricted stock units issued and outstanding 6,573,473 Remaining shares available for issuance under the 2021 Plan 2,207,333 Shares available for issuance under the 2023 Inducement Plan 1,139,968 ESPP 1,334,366 Common stock warrants 105,350 Total 18,748,138
Schedule of Stock Option Activity under Stock Plans	The following table summarizes stock option activity under the Stock Plans for the three months ended April 30, 2023 (aggregate intrinsic value in thousands): Options Outstanding Weighted- Aggregate Number of Weighted- Balances as of January 31, 2023 7,819,480 $ 9.78 5.21 $ 51,606 Options exercised (389,377) $ 4.92 Options granted — $ — Options cancelled (42,455) $ 19.59 Balances as of April 30, 2023 7,387,648 $ 9.98 5.18 $ 50,996 Options vested and expected to vest as of April 30, 2023 7,387,648 $ 9.98 5.18 $ 50,996 Options vested and exercisable as of April 30, 2023 6,318,721 $ 8.62 4.76 $ 48,584
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity	The following table is a summary of service-based RSU activity for the three months ended April 30, 2023: RSUs Outstanding Number of RSUs Weighted Average Grant Date Fair Value Per Share Balances as of January 31, 2023 3,442,982 $ 18.39 RSUs granted 2,415,445 $ 16.26 RSUs vested (259,980) $ 19.88 RSUs forfeited (154,974) $ 17.62 Balances as of April 30, 2023 5,443,473 $ 17.39
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The fair value of employee stock purchase rights for the offering period under the 2021 ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: Three Months Ended April 30, 2023 2022 Employee Stock Purchase Plan: Expected term (in years) 0.8 1.6 Expected volatility 66.9 % 49.4 % Risk-free interest rate 4.8 % 0.2 % Dividend yield — —
Schedule of Stock-Based Compensation Expense	Stock-Based Compensation Stock-based compensation expense, net of amounts capitalized was as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of revenue—subscription $ 193 $ 122 Cost of revenue—services 145 94 Research and development 2,768 1,899 Sales and marketing 3,241 1,987 General and administrative 2,928 1,348 Restructuring 1 — Total stock-based compensation expense $ 9,276 $ 5,450

Restructuring (Tables)

Restructuring (Tables)	3 Months Ended
Restructuring (Tables)	Apr. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Expense	Restructuring expense was as follows (in thousands): Three Months Ended April 30, 2023 Employee severance and related costs $ 45 Stock-based compensation 1 Total restructuring charges $ 46
Schedule of Restructuring Liabilities	The activity in our restructuring liabilities for the three months ended April 30, 2023 is as follows (in thousands): Total Balance as of January 31, 2023 $ 1,567 Restructuring charges and adjustments 45 Payments (1,538) Balance as of April 30, 2023 $ 74

Geographic Information (Tables)

Geographic Information (Tables)	3 Months Ended
Geographic Information (Tables)	Apr. 30, 2023
Segment Reporting [Abstract]
Schedule of Disaggregation of Revenue by Geographic Area	The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands): Three Months Ended April 30, 2023 2022 United States $ 25,991 $ 21,336 International 15,005 13,517 Total $ 40,996 $ 34,853

Net Loss per Share (Tables)

Net Loss per Share (Tables)	3 Months Ended
Net Loss per Share (Tables)	Apr. 30, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended April 30, 2023 2022 Numerator Net loss $ (21,875) $ (19,834) Denominator Weighted-average shares used in computing net loss per share, basic and diluted 45,843 44,265 Net loss per share, basic and diluted $ (0.48) $ (0.45)
Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands): Three Months Ended April 30, 2023 2022 Stock options 7,388 8,604 RSUs 6,983 3,957 Employee stock purchase rights under the ESPP 118 138 Common stock warrants 105 105 Total 14,594 12,804

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) - Customer A - Accounts Receivable - Customer Concentration Risk - customer	3 Months Ended	12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	11%	12%
Number of customers	1	1

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Summary of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash equivalents, amortized cost	$ 13,484	$ 30,361
Cash equivalents, estimate fair value	13,484	30,361
Short-Term Investments
Amortized Cost	117,893	128,663
Gross Unrealized Gains	16	4
Gross Unrealized Losses	(506)	(811)
Estimated Fair Value	117,403	127,856
Amortized Cost	131,377	159,024
Estimated Fair Value	130,887	158,217
U.S. government treasury securities
Short-Term Investments
Amortized Cost	63,309	71,981
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(452)	(729)
Estimated Fair Value	62,857	71,253
Commercial paper
Short-Term Investments
Amortized Cost	25,597	31,500
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	25,597	31,500
U.S. government agency securities
Short-Term Investments
Amortized Cost	11,881	7,839
Gross Unrealized Gains	16	3
Gross Unrealized Losses	(2)	(1)
Estimated Fair Value	11,895	7,841
Corporate debt securities
Short-Term Investments
Amortized Cost	11,919	11,952
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(25)	(50)
Estimated Fair Value	11,894	11,902
Asset-backed securities
Short-Term Investments
Amortized Cost	5,187	5,391
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(27)	(31)
Estimated Fair Value	5,160	5,360
Money market funds
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash equivalents, amortized cost	13,484	29,239
Cash equivalents, estimate fair value	$ 13,484	29,239
Corporate debt securities
Schedule Of Cash Cash Equivalents And Short Term Investments
Cash equivalents, amortized cost		1,122
Cash equivalents, estimate fair value		$ 1,122

Cash Equivalents and Short Term

Cash Equivalents and Short Term Investments - Additional Information (Details)	3 Months Ended
	Apr. 30, 2023 USD ($) investment	Apr. 30, 2022 USD ($)	Jan. 31, 2023 USD ($) investment
Cash and Cash Equivalents [Abstract]
Reclassify from accumulated other comprehensive income (loss)	$ 0	$ 0
Contractual maturity in one year	111,400,000		$ 122,000,000
Contractual maturity greater than one year	$ 6,000,000		$ 5,900,000
Number of short-term investments in unrealized loss position \| Investment \| investment	28		27

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Summary of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Debt Securities, Available-for-Sale, Unrealized Loss Position
Short-term investments, less than 12 months, unrealized Losses	$ (189)	$ (810)
Short-term investments, less than 12 months, fair value	58,238	80,583
Short-term investments,12 months or greater, unrealized Losses	(317)	(1)
Short-term investments, 12 months or greater, fair value	24,615	1,999
Short-term investments, unrealized Losses	(506)	(811)
Debt Securities, Available-for-Sale, Unrealized Loss Position, Total	82,853	82,582
U.S. government treasury securities
Debt Securities, Available-for-Sale, Unrealized Loss Position
Short-term investments, less than 12 months, unrealized Losses	(135)	(729)
Short-term investments, less than 12 months, fair value	38,243	64,397
Short-term investments,12 months or greater, unrealized Losses	(317)	0
Short-term investments, 12 months or greater, fair value	24,615	0
Short-term investments, unrealized Losses	(452)	(729)
Debt Securities, Available-for-Sale, Unrealized Loss Position, Total	62,858	64,397
Corporate debt securities
Debt Securities, Available-for-Sale, Unrealized Loss Position
Short-term investments, less than 12 months, unrealized Losses	(25)	(49)
Short-term investments, less than 12 months, fair value	10,894	8,909
Short-term investments,12 months or greater, unrealized Losses	0	(1)
Short-term investments, 12 months or greater, fair value	0	1,999
Short-term investments, unrealized Losses	(25)	(50)
Debt Securities, Available-for-Sale, Unrealized Loss Position, Total	10,894	10,908
Asset-backed securities
Debt Securities, Available-for-Sale, Unrealized Loss Position
Short-term investments, less than 12 months, unrealized Losses	(27)	(31)
Short-term investments, less than 12 months, fair value	5,160	5,359
Short-term investments,12 months or greater, unrealized Losses	0	0
Short-term investments, 12 months or greater, fair value	0	0
Short-term investments, unrealized Losses	(27)	(31)
Debt Securities, Available-for-Sale, Unrealized Loss Position, Total	5,160	5,359
U.S. government agency securities
Debt Securities, Available-for-Sale, Unrealized Loss Position
Short-term investments, less than 12 months, unrealized Losses	(2)	(1)
Short-term investments, less than 12 months, fair value	3,941	1,918
Short-term investments,12 months or greater, unrealized Losses	0	0
Short-term investments, 12 months or greater, fair value	0	0
Short-term investments, unrealized Losses	(2)	(1)
Debt Securities, Available-for-Sale, Unrealized Loss Position, Total	$ 3,941	$ 1,918

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 13,484	$ 30,361
Total short-term investments	117,403	127,856
U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	62,857	71,253
Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	25,597	31,500
U.S. government agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,895	7,841
Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,894	11,902
Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	5,160	5,360
Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	13,484	29,239
Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents		1,122
Fair Value, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	13,484	30,361
Total short-term investments	117,403	127,856
Total	130,887	158,217
Fair Value, Recurring \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	62,857	71,253
Fair Value, Recurring \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	25,597	31,500
Fair Value, Recurring \| U.S. government agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,895	7,841
Fair Value, Recurring \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,894	11,902
Fair Value, Recurring \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	5,160	5,360
Fair Value, Recurring \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	13,484	29,239
Total short-term investments	0	0
Total	13,484	29,239
Fair Value, Recurring \| Level 1 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| U.S. government agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 1 \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	0	0
Fair Value, Recurring \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	0	1,122
Total short-term investments	117,403	127,856
Total	117,403	128,978
Fair Value, Recurring \| Level 2 \| U.S. government treasury securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	62,857	71,253
Fair Value, Recurring \| Level 2 \| Commercial paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	25,597	31,500
Fair Value, Recurring \| Level 2 \| U.S. government agency securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,895	7,841
Fair Value, Recurring \| Level 2 \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	11,894	11,902
Fair Value, Recurring \| Level 2 \| Asset-backed securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total short-term investments	5,160	5,360
Fair Value, Recurring \| Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	13,484	29,239
Fair Value, Recurring \| Money market funds \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	13,484	29,239
Fair Value, Recurring \| Money market funds \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 0	0
Fair Value, Recurring \| Corporate debt securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents		1,122
Fair Value, Recurring \| Corporate debt securities \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents		0
Fair Value, Recurring \| Corporate debt securities \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents		$ 1,122

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 2,860	$ 4,140
Prepaid software	3,143	2,560
Other current assets	836	1,534
Total prepaid expenses and other current assets	$ 6,839	$ 8,234

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Property Plant And Equipment
Total gross property and equipment	$ 18,564	$ 17,096
Accumulated depreciation and amortization	(10,532)	(9,666)
Total property and equipment, net	8,032	7,430
Computer equipment
Property Plant And Equipment
Total gross property and equipment	3,562	3,586
Furniture and fixtures
Property Plant And Equipment
Total gross property and equipment	342	342
Capitalized internal-use software
Property Plant And Equipment
Total gross property and equipment	8,435	7,884
Leasehold improvements
Property Plant And Equipment
Total gross property and equipment	1,889	1,889
Construction in progress—capitalized internal-use software
Property Plant And Equipment
Total gross property and equipment	$ 4,336	$ 3,395

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information of Property and Equipment Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Property Plant And Equipment
Depreciation and amortization	$ 890	$ 739
Capitalized internal-use software
Property Plant And Equipment
Depreciation and amortization	$ 700	$ 500

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Accrued Compensation and Benefits
Accrued bonus	$ 2,528	$ 5,944
Accrued commissions	3,442	3,593
Accrued payroll and benefits	2,041	1,995
Employee contributions under the ESPP	484	1,109
Total accrued compensation and benefits	$ 8,495	$ 12,641

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Other Accrued Expenses (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Other Accrued Liabilities
Accrued professional fees	$ 913	$ 1,020
Sales and value added tax payable	830	737
Income taxes payable	1,064	743
Accrued restructuring	74	1,567
Other	1,932	2,009
Total other accrued expenses	$ 4,813	$ 6,076

Deferred Revenue and Remainin_3

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023	Apr. 30, 2022	Jan. 31, 2022
Contract with Customer, Liability
Deferred revenue, current	$ 78,540	$ 71,716
Deferred revenue, noncurrent	2,874	3,275
Total deferred revenue	$ 81,414	$ 74,991	$ 70,755	$ 71,723

Deferred Revenue and Remainin_4

Deferred Revenue and Remaining Performance Obligations - Schedule of Changes In Deferred Revenue Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Change In Contract With Customer, Liability
Beginning balance	$ 74,991	$ 71,723
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(29,061)	(24,207)
Increases due to invoicing prior to satisfaction of performance obligations	35,484	23,239
Ending balance	$ 81,414	$ 70,755

Deferred Revenue and Remainin_5

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) $ in Millions	Apr. 30, 2023 USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 165.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-05-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 112.1
Revenue expected to be recognized from remaining performance obligations, period (in months)	12 months

Debt - Additional Information (

Debt - Additional Information (Details)		3 Months Ended		12 Months Ended
Debt - Additional Information (Details)	Jan. 31, 2022	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)	Jan. 31, 2022 USD ($)	Jun. 05, 2023 USD ($)	Jun. 30, 2020 USD ($)	Apr. 30, 2019 USD ($) $ / shares shares
Debt Instrument
Interest expense, debt		$ 0	$ 0
Fair value of common stock							$ 400,000
Credit Facility
Debt Instrument
Borrowed line of credit				$ 25,000,000
Line of credit facility adjusted quick ratio	1.15
Fee payable on unused portion of line of credit (as a percent)	0.25%
Line of credit outstanding		0
Current borrowing capacity		$ 40,000,000
Credit Facility \| Subsequent Event
Debt Instrument
Line of credit outstanding					$ 0
Credit Facility \| Minimum
Debt Instrument
Line of credit facility termination fee (as a percent)	50%
Credit Facility \| Maximum
Debt Instrument
Line of credit facility termination fee (as a percent)	100%
Credit Facility \| Prime Rate
Debt Instrument
Variable rate (as a percent)	0.50%
Amended Loan \| Loans Payable
Debt Instrument
Maximum borrowing capacity						$ 25,000,000
Warrants issued to purchase common stock (in shares) \| shares							105,350
Exercise price of warrants or rights (in dollars per share) \| $ / shares							$ 7.48
Warrants exercisable period (in years)							10 years

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Apr. 30, 2023	Apr. 30, 2022
Lessee, Lease, Description
Operating lease cost	$ 0.8	$ 0.6
Variable lease cost	0.1	0.2
Short-term lease cost	$ 0	$ 0
Maximum
Lessee, Lease, Description
Lease term (up to) (in years)	3 years

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$ 823	$ 661
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 0	$ 1,509

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Operating Lease, Assets And Liabilities, Lessee [Abstract]
Operating lease right-of-use assets	$ 6,233	$ 6,940
Operating lease liabilities	3,060	3,117
Operating lease liabilities, noncurrent	3,873	4,543
Total operating lease liabilities	$ 6,933	$ 7,660
Weighted-average remaining lease term (term)	2 years 6 months	2 years 8 months 12 days
Weighted-average discount rate (percent)	3.80%	3.80%

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Operating Leases
Remaining for Fiscal 2024	$ 2,492
Fiscal 2025	2,988
Fiscal 2026	1,183
Fiscal 2027	353
Fiscal 2028 and thereafter	251
Total lease payments	7,267
Less: imputed interest	(334)
Total operating lease liabilities	$ 6,933	$ 7,660

Stockholders_ Equity and Empl_3

Stockholders’ Equity and Employee Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended		6 Months Ended	12 Months Ended
	Mar. 20, 2023 shares	Mar. 21, 2022 period	Jul. 31, 2021 participant $ / shares shares	Apr. 30, 2023 USD ($) vote $ / shares shares	Apr. 30, 2022 USD ($) shares	Sep. 21, 2021	Jan. 31, 2023 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award
Preferred stock, shares authorized (in shares)			200,000,000	200,000,000			200,000,000
Preferred stock, par value (in dollars per share) \| $ / shares			$ 0.00001	$ 0.00001			$ 0.00001
Common stock, shares authorized (in shares)				1,000,000,000			1,000,000,000
Common stock, par value (in dollars per share) \| $ / shares				$ 0.00001			$ 0.00001
Number of vote \| vote				1
Dividend declared (in dollars per share) \| $ / shares				$ 0			$ 0
Number of shares reserved common stock for future issuance (in shares)				18,748,138
Initial offering period duration (in months)						24 months
Initial offering number of purchase periods \| period		4
Total stock-based compensation expense \| $				$ 9,276	$ 5,450
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Number of shares reserved common stock for future issuance (in shares)				7,387,648
Total stock-based compensation expense \| $				$ 1,200	$ 1,700
Unrecognized stock-based compensation expense related to unvested stock options \| $				$ 7,500
Stock-based compensation expected to be recognized weighted-average period (in years)				1 year 6 months
Options granted (in shares)				0	0
Aggregate intrinsic value of options exercised \| $				$ 4,200	$ 6,700
Issuance of common stock upon exercise of stock options (in shares)				389,377
Service-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Total stock-based compensation expense \| $				$ 6,800	2,400
Stock-based compensation expected to be recognized weighted-average period (in years)				2 years 8 months 12 days
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number (in shares)				5,443,473			3,442,982
Aggregate fair value of RSU granted \| $				$ 39,300	49,700
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $				$ 86,400
RSUs granted (in shares)				2,415,445
Market-Based Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award
Stock-based compensation expected to be recognized weighted-average period (in years)				1 year 6 months
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $				$ 2,200
Incremental stock-based compensation expense related to these modified awards \| $				0
Market-Based Restricted Stock Units (RSUs) \| Executive Officers And Members Of Senior Management
Share Based Compensation Arrangement By Share Based Payment Award
Outstanding RSU granted (in shares)	1,060,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number (in shares)	220,000
Performance-based Awards
Share Based Compensation Arrangement By Share Based Payment Award
Total stock-based compensation expense \| $				$ 700
Stock-based compensation expected to be recognized weighted-average period (in years)				1 year 7 months 6 days
Unrecognized stock-based compensation expense related to service vesting-based RSUs \| $				$ 9,900
Incremental stock-based compensation expense related to these modified awards \| $				6,000
Incremental stock-based compensation expense related to these modified awards recognized \| $				$ 400
Performance-based Awards \| Executive Officers And Members Of Senior Management
Share Based Compensation Arrangement By Share Based Payment Award
RSUs granted (in shares)	840,000
2021 Plan
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation granted expiration period (in years)				10 years
Share-based compensation vesting period (in years)				4 years
Share-based compensation available for grant (in shares)				2,200,000
Number of shares reserved common stock for future issuance (in shares)				4,120,000
Share-based compensation percentage of outstanding stock (as a percent)				5%
2021 Plan \| Performance-based Awards \| Executive Officer
Share Based Compensation Arrangement By Share Based Payment Award
Aggregate fair value of RSU granted \| $				$ 700
RSUs granted (in shares)				70,000,000
2021 Plan \| First Anniversary
Share Based Compensation Arrangement By Share Based Payment Award
Share-based compensation vesting rights (as a percent)				25%
ESPP
Share Based Compensation Arrangement By Share Based Payment Award
Employee maximum contribution (as a percent)			15%
Discount rate on market value of share (as a percent)			85%
Number of participant may purchase more than 1000 shares \| participant			0
Total stock-based compensation expense \| $				$ 300	$ 800
Employee contributions under the ESPP \| $				500
Unrecognized stock-based compensation expense related to unvested stock options \| $				$ 900
Stock-based compensation expected to be recognized weighted-average period (in years)				8 months 12 days
Share purchases related to ESPP (in shares)				74,113
Inducement Equity Incentive Plan 2023
Share Based Compensation Arrangement By Share Based Payment Award
Number of shares authorized (in shares)							1,300,000
IPO
Share Based Compensation Arrangement By Share Based Payment Award
Number of common stock for sale and issuance (in shares)				0
Number of shares outstanding (in shares)				0

Stockholders_ Equity and Empl_4

Stockholders’ Equity and Employee Incentive Plans - Summary of Reserved Common Stock for Future Issuance (Details)	Apr. 30, 2023 shares
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	18,748,138
Stock options outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	7,387,648
Restricted stock units issued and outstanding
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	6,573,473
Remaining shares available for issuance under the 2021 Plan
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	2,207,333
Remaining shares available for issuance under the 2021 Plan \| Inducement Equity Incentive Plan 2023
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	1,139,968
ESPP
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	1,334,366
Common stock warrants
Class Of Stock
Number of shares reserved common stock for future issuance (in shares)	105,350

Stockholders_ Equity and Empl_5

Stockholders’ Equity and Employee Incentive Plans - Summary of Stock Option Activity under Stock Plans (Details) - Stock options outstanding - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Options Outstanding, Number of Options
Beginning balance (in shares)	7,819,480
Options exercised (in shares)	(389,377)
Options granted (in shares)	0	0
Options cancelled (in shares)	(42,455)
Ending balance (in shares)	7,387,648		7,819,480
Options vested and expected to vest (in shares)	7,387,648
Options vested and exercisable (in shares)	6,318,721
Options Outstanding, Weighted Average Exercise Price
Beginning balance (in dollars per share)	$ 9.78
Options exercised (in dollars per share)	4.92
Options granted (in dollars per share)	0
Options cancelled (in dollars per share)	19.59
Ending balance (in dollars per share)	9.98		$ 9.78
Options vested and expected to vest (in dollars per share)	9.98
Options vested and exercisable (in dollars per share)	$ 8.62
Stock Options Additional Disclosures
Options outstanding, weighted average remaining contractual term (in years)	5 years 2 months 4 days		5 years 2 months 15 days
Options vested and expected to vest, weighted-average contractual term (in years)	5 years 2 months 4 days
Options vested and exercisable, weighted-average contractual term (in years)	4 years 9 months 3 days
Options outstanding, aggregate intrinsic value	$ 50,996		$ 51,606
Options vested and expected to vest, aggregate intrinsic value	50,996
Options vested and exercisable, aggregate intrinsic value	$ 48,584

Stockholders_ Equity and Empl_6

Stockholders’ Equity and Employee Incentive Plans - Summary of RSU Activity (Details) - Service-Based Restricted Stock Units (RSUs)	3 Months Ended
	Apr. 30, 2023 $ / shares shares
RSUs Outstanding, Number of RSUs
Beginning balance (in shares) \| shares	3,442,982
RSUs granted (in shares) \| shares	2,415,445
RSUs vested (in shares) \| shares	(259,980)
RSUs forfeited (in shares) \| shares	(154,974)
Ending balance (in shares) \| shares	5,443,473
RSUs Outstanding, Weighted Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 18.39
RSUs granted (in dollars per share) \| $ / shares	16.26
RSUs vested (in dollars per share) \| $ / shares	19.88
RSUs forfeited (in dollars per share) \| $ / shares	17.62
Ending balance (in dollars per share) \| $ / shares	$ 17.39

Stockholders_ Equity and Empl_7

Stockholders’ Equity and Employee Incentive Plans - Summary of Fair Value of Employee Stock Options Estimated using Weighted-Average Assumptions (Details) - shares	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Stock options outstanding
Share Based Compensation Arrangement By Share Based Payment Award
Options granted (in shares)	0	0

Stockholders_ Equity and Empl_8

Stockholders’ Equity and Employee Incentive Plans - Summary of Weighted-Average Assumptions Used In Estimating Fair Value of Employee Stock Purchase Rights (Details) - 2021 ESPP - Stock options outstanding	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award
Expected term (in years)	9 months 18 days	1 year 7 months 6 days
Expected volatility (as a percent)	66.90%	49.40%
Risk-free interest rate (as a percent)	4.80%	0.20%
Dividend yield	0%	0%

Stockholders_ Equity and Empl_9

Stockholders’ Equity and Employee Incentive Plans - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 9,276	$ 5,450
Research and development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	2,768	1,899
Sales and marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	3,241	1,987
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	2,928	1,348
Restructuring
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	1	0
Cost of revenue—subscription \| Cost of revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	193	122
Cost of revenue—services \| Cost of revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs
Recognized stock-based compensation expense	$ 145	$ 94

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Income Tax Disclosure [Abstract]
Income tax expense	$ 750	$ 265

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	$ 46	$ 0
Employee severance and related costs
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	45
Stock-based compensation
Restructuring Cost and Reserve [Line Items]
Total restructuring charges	$ 1

Restructuring - Schedule of R_2

Restructuring - Schedule of Restructuring Liabilities (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2023 USD ($)
Restructuring Reserve
Balance as of January 31, 2023	$ 1,567
Restructuring charges and adjustments	45
Payments	(1,538)
Balance as of April 30, 2023	$ 74

Geographic Information - Schedu

Geographic Information - Schedule of Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Segment Reporting Information
Total revenue	$ 40,996	$ 34,853
United States
Segment Reporting Information
Total revenue	25,991	21,336
International
Segment Reporting Information
Total revenue	$ 15,005	$ 13,517

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Numerator
Net loss	$ (21,875)	$ (19,834)
Denominator
Weighted-average shares used in computing net loss per share, basic (in shares)	45,843	44,265
Weighted-average shares used in computing net loss per share, diluted (in shares)	45,843	44,265
Net loss per share, basic (in dollars per share)	$ (0.48)	$ (0.45)
Net loss per share, diluted (in dollars per share)	$ (0.48)	$ (0.45)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	14,594	12,804
Stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	7,388	8,604
RSUs
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	6,983	3,957
Employee stock purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	118	138
Common stock warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share
Potentially dilutive securities were excluded from computation of diluted net loss per share (in shares)	105	105

Subsequent Event (Details)

Subsequent Event (Details) - Credit Facility - USD ($)	Jun. 05, 2023	Apr. 30, 2023
Subsequent Event [Line Items]
Line of credit outstanding		$ 0
Subsequent Event
Subsequent Event [Line Items]
Line of credit outstanding	$ 0